Literature DB >> 26119230

Treatment Sequencing in Metastatic Castration-Resistant Prostate Cancer: A Clinical Commentary.

Cy A Stein1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26119230     DOI： 10.1016/j.clgc.2015.05.005

Source DB:  PubMed          Journal:  Clin Genitourin Cancer        ISSN： 1558-7673            Impact factor:   2.872


× No keyword cloud information.
  3 in total

1.  6BIO Enhances Oligonucleotide Activity in Cells: A Potential Combinatorial Anti-androgen Receptor Therapy in Prostate Cancer Cells.

Authors:  Xiaowei Zhang; Daniela Castanotto; Sangkil Nam; David Horne; Cy Stein
Journal:  Mol Ther       Date:  2017-01-04       Impact factor: 11.454

Review 2.  Multiwalled Carbon Nanotubes as Nanomaterial Tool in the Management of Prostate Cancer: A Possible Nanoformulation Approach.

Authors:  Raja Murugesan; Raman Sureshkumar; Arun Radhakrishnan; Srikanth Jupudi; Manisha Chennu
Journal:  Adv Pharm Bull       Date:  2021-09-29

3.  SMC1A is associated with radioresistance in prostate cancer and acts by regulating epithelial-mesenchymal transition and cancer stem-like properties.

Authors:  Sushma Yadav; Claudia M Kowolik; Min Lin; Darren Zuro; Susanta K Hui; Arthur D Riggs; David A Horne
Journal:  Mol Carcinog       Date:  2018-10-05       Impact factor: 4.784
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.